IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.
Published July 8, 2026 · Recall initiated: June 10, 2026
Summary
FDA records drug Class II recall D-0653-2026, published July 8, 2026 and initiated June 10, 2026. Recalling firm: ACCORD BIOPHARMA INC; Status: Ongoing; Reported quantity: 326 vials; Lot: Lot # 004L24A, Exp Date: 02/19/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of Sterility:
What to do
Voluntary: Firm initiated · Letter
Get an email if IMULDOSA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IMULDOSA
- Manufacturer
- ACCORD BIOPHARMA INC
- Distributor
- US Nationwide.
- UPC
- 0369448017637
- Lot
- Lot # 004L24A, Exp Date: 02/19/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 100 x 10.5 mLJuly 8, 2026
- FDAFexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: OhmJuly 8, 2026
- FDABD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol),500 x 1 mLJuly 8, 2026
- FDAprednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mLJuly 8, 2026
- FDABD ChloraPrep Scrub Teal, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) packaged as a)July 8, 2026
- FDALevothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: AccordJuly 8, 2026
Questions about this recall
Was IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26. recalled?
Yes. FDA published recall D-0653-2026 on July 8, 2026. Reported hazard: Lack of assurance of Sterility:
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IMULDOSA. UPC: 0369448017637.